カテゴリ： 世界, 医療/バイオ, Market Monitor Global

ヒト血漿タンパク質製品のグローバル市場展望 2023年-2029年：免疫グロブリン、凝固因子、アルブミン、その他

■ 英語タイトル：Human Plasma Protein Products Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14366）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14366
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：108
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ヒト血漿タンパク質製品のグローバル市場展望 2023年-2029年：免疫グロブリン、凝固因子、アルブミン、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のヒト血漿タンパク質製品市場規模と予測を収録しています。・世界のヒト血漿タンパク質製品市場：売上、2018年-2023年、2024年-2029年
・世界のヒト血漿タンパク質製品市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のヒト血漿タンパク質製品市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「免疫グロブリン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

ヒト血漿タンパク質製品のグローバル主要企業は、Takeda、 CSL、 Grifols、 Octapharma、 Kedrion、 LFB Group、 Biotest、 BPL、 RAAS、 CBPO、 Hualan Bio、 Tiantan Bio、 Shuanglin Bio、 Boya Bio、 Yuanda Shuyang、 Weiguang Bio、 Nanyue Bio、 KM Biologicsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、ヒト血漿タンパク質製品のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のヒト血漿タンパク質製品市場：タイプ別、2018年-2023年、2024年-2029年
世界のヒト血漿タンパク質製品市場：タイプ別市場シェア、2022年
・免疫グロブリン、凝固因子、アルブミン、その他

世界のヒト血漿タンパク質製品市場：用途別、2018年-2023年、2024年-2029年
世界のヒト血漿タンパク質製品市場：用途別市場シェア、2022年
・病院、小売薬局、その他

世界のヒト血漿タンパク質製品市場：地域・国別、2018年-2023年、2024年-2029年
世界のヒト血漿タンパク質製品市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるヒト血漿タンパク質製品のグローバル売上、2018年-2023年
・主要企業におけるヒト血漿タンパク質製品のグローバル売上シェア、2022年
・主要企業におけるヒト血漿タンパク質製品のグローバル販売量、2018年-2023年
・主要企業におけるヒト血漿タンパク質製品のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Takeda、 CSL、 Grifols、 Octapharma、 Kedrion、 LFB Group、 Biotest、 BPL、 RAAS、 CBPO、 Hualan Bio、 Tiantan Bio、 Shuanglin Bio、 Boya Bio、 Yuanda Shuyang、 Weiguang Bio、 Nanyue Bio、 KM Biologics

*************************************************************

・調査・分析レポートの概要
ヒト血漿タンパク質製品市場の定義
市場セグメント
世界のヒト血漿タンパク質製品市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のヒト血漿タンパク質製品市場規模
世界のヒト血漿タンパク質製品市場規模：2022年 VS 2029年
世界のヒト血漿タンパク質製品市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのヒト血漿タンパク質製品の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のヒト血漿タンパク質製品製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：免疫グロブリン、凝固因子、アルブミン、その他
ヒト血漿タンパク質製品のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、小売薬局、その他
ヒト血漿タンパク質製品の用途別グローバル売上・予測

・地域別市場分析
地域別ヒト血漿タンパク質製品市場規模 2022年と2029年
地域別ヒト血漿タンパク質製品売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Takeda、 CSL、 Grifols、 Octapharma、 Kedrion、 LFB Group、 Biotest、 BPL、 RAAS、 CBPO、 Hualan Bio、 Tiantan Bio、 Shuanglin Bio、 Boya Bio、 Yuanda Shuyang、 Weiguang Bio、 Nanyue Bio、 KM Biologics
...

This research report provides a comprehensive analysis of the Human Plasma Protein Products market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Human Plasma Protein Products market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Human Plasma Protein Products, challenges faced by the industry, and potential opportunities for market players.
The global Human Plasma Protein Products market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Human Plasma Protein Products market presents opportunities for various stakeholders, including Hospital, Retail Pharmacy. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Human Plasma Protein Products market. Additionally, the growing consumer demand present avenues for market expansion.
The global Human Plasma Protein Products market was valued at US$ 28610 million in 2022 and is projected to reach US$ 48950 million by 2029, at a CAGR of 8.0% during the forecast period.
The Human Plasma Fractionation Product Market is driven by the increasing demand for plasma-derived therapies and the rising prevalence of various diseases. These products, including clotting factors and immunoglobulins, are crucial for treating rare and life-threatening conditions. However, a significant challenge is the need for a stable supply of plasma donations and the complex fractionation processes required to manufacture these products. Ensuring the safety and quality of plasma-derived therapies through strict regulatory compliance is another challenge for manufacturers. Additionally, market competition and pricing pressures pose challenges, necessitating a balance between affordability and sustaining the supply chain to meet the healthcare demands while maintaining the highest standards of patient care.
Key Features:
The research report on the Human Plasma Protein Products market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Human Plasma Protein Products market.
Market Overview: The report provides a comprehensive overview of the Human Plasma Protein Products market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Immune Globulin, Coagulation Factor), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Human Plasma Protein Products market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Human Plasma Protein Products market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Human Plasma Protein Products market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Human Plasma Protein Products market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Human Plasma Protein Products market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Human Plasma Protein Products market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Human Plasma Protein Products, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Human Plasma Protein Products market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Human Plasma Protein Products market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Immune Globulin
Coagulation Factor
Albumin
Other
Market segment by Application
Hospital
Retail Pharmacy
Other
Global Human Plasma Protein Products Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Tiantan Bio
Shuanglin Bio
Boya Bio
Yuanda Shuyang
Weiguang Bio
Nanyue Bio
KM Biologics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Human Plasma Protein Products, market overview.
Chapter 2: Global Human Plasma Protein Products market size in revenue.
Chapter 3: Detailed analysis of Human Plasma Protein Products company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Human Plasma Protein Products in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Human Plasma Protein Products Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Human Plasma Protein Products Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Human Plasma Protein Products Overall Market Size
2.1 Global Human Plasma Protein Products Market Size: 2022 VS 2029
2.2 Global Human Plasma Protein Products Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Human Plasma Protein Products Players in Global Market
3.2 Top Global Human Plasma Protein Products Companies Ranked by Revenue
3.3 Global Human Plasma Protein Products Revenue by Companies
3.4 Top 3 and Top 5 Human Plasma Protein Products Companies in Global Market, by Revenue in 2022
3.5 Global Companies Human Plasma Protein Products Product Type
3.6 Tier 1, Tier 2 and Tier 3 Human Plasma Protein Products Players in Global Market
3.6.1 List of Global Tier 1 Human Plasma Protein Products Companies
3.6.2 List of Global Tier 2 and Tier 3 Human Plasma Protein Products Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Human Plasma Protein Products Market Size Markets, 2022 & 2029
4.1.2 Immune Globulin
4.1.3 Coagulation Factor
4.1.4 Albumin
4.1.5 Other
4.2 By Type – Global Human Plasma Protein Products Revenue & Forecasts
4.2.1 By Type – Global Human Plasma Protein Products Revenue, 2018-2023
4.2.2 By Type – Global Human Plasma Protein Products Revenue, 2024-2029
4.2.3 By Type – Global Human Plasma Protein Products Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Human Plasma Protein Products Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application – Global Human Plasma Protein Products Revenue & Forecasts
5.2.1 By Application – Global Human Plasma Protein Products Revenue, 2018-2023
5.2.2 By Application – Global Human Plasma Protein Products Revenue, 2024-2029
5.2.3 By Application – Global Human Plasma Protein Products Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Human Plasma Protein Products Market Size, 2022 & 2029
6.2 By Region – Global Human Plasma Protein Products Revenue & Forecasts
6.2.1 By Region – Global Human Plasma Protein Products Revenue, 2018-2023
6.2.2 By Region – Global Human Plasma Protein Products Revenue, 2024-2029
6.2.3 By Region – Global Human Plasma Protein Products Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Human Plasma Protein Products Revenue, 2018-2029
6.3.2 US Human Plasma Protein Products Market Size, 2018-2029
6.3.3 Canada Human Plasma Protein Products Market Size, 2018-2029
6.3.4 Mexico Human Plasma Protein Products Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Human Plasma Protein Products Revenue, 2018-2029
6.4.2 Germany Human Plasma Protein Products Market Size, 2018-2029
6.4.3 France Human Plasma Protein Products Market Size, 2018-2029
6.4.4 U.K. Human Plasma Protein Products Market Size, 2018-2029
6.4.5 Italy Human Plasma Protein Products Market Size, 2018-2029
6.4.6 Russia Human Plasma Protein Products Market Size, 2018-2029
6.4.7 Nordic Countries Human Plasma Protein Products Market Size, 2018-2029
6.4.8 Benelux Human Plasma Protein Products Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Human Plasma Protein Products Revenue, 2018-2029
6.5.2 China Human Plasma Protein Products Market Size, 2018-2029
6.5.3 Japan Human Plasma Protein Products Market Size, 2018-2029
6.5.4 South Korea Human Plasma Protein Products Market Size, 2018-2029
6.5.5 Southeast Asia Human Plasma Protein Products Market Size, 2018-2029
6.5.6 India Human Plasma Protein Products Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Human Plasma Protein Products Revenue, 2018-2029
6.6.2 Brazil Human Plasma Protein Products Market Size, 2018-2029
6.6.3 Argentina Human Plasma Protein Products Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Human Plasma Protein Products Revenue, 2018-2029
6.7.2 Turkey Human Plasma Protein Products Market Size, 2018-2029
6.7.3 Israel Human Plasma Protein Products Market Size, 2018-2029
6.7.4 Saudi Arabia Human Plasma Protein Products Market Size, 2018-2029
6.7.5 UAE Human Plasma Protein Products Market Size, 2018-2029
7 Human Plasma Protein Products Companies Profiles
7.1 Takeda
7.1.1 Takeda Company Summary
7.1.2 Takeda Business Overview
7.1.3 Takeda Human Plasma Protein Products Major Product Offerings
7.1.4 Takeda Human Plasma Protein Products Revenue in Global Market (2018-2023)
7.1.5 Takeda Key News & Latest Developments
7.2 CSL
7.2.1 CSL Company Summary
7.2.2 CSL Business Overview
7.2.3 CSL Human Plasma Protein Products Major Product Offerings
7.2.4 CSL Human Plasma Protein Products Revenue in Global Market (2018-2023)
7.2.5 CSL Key News & Latest Developments
7.3 Grifols
7.3.1 Grifols Company Summary
7.3.2 Grifols Business Overview
7.3.3 Grifols Human Plasma Protein Products Major Product Offerings
7.3.4 Grifols Human Plasma Protein Products Revenue in Global Market (2018-2023)
7.3.5 Grifols Key News & Latest Developments
7.4 Octapharma
7.4.1 Octapharma Company Summary
7.4.2 Octapharma Business Overview
7.4.3 Octapharma Human Plasma Protein Products Major Product Offerings
7.4.4 Octapharma Human Plasma Protein Products Revenue in Global Market (2018-2023)
7.4.5 Octapharma Key News & Latest Developments
7.5 Kedrion
7.5.1 Kedrion Company Summary
7.5.2 Kedrion Business Overview
7.5.3 Kedrion Human Plasma Protein Products Major Product Offerings
7.5.4 Kedrion Human Plasma Protein Products Revenue in Global Market (2018-2023)
7.5.5 Kedrion Key News & Latest Developments
7.6 LFB Group
7.6.1 LFB Group Company Summary
7.6.2 LFB Group Business Overview
7.6.3 LFB Group Human Plasma Protein Products Major Product Offerings
7.6.4 LFB Group Human Plasma Protein Products Revenue in Global Market (2018-2023)
7.6.5 LFB Group Key News & Latest Developments
7.7 Biotest
7.7.1 Biotest Company Summary
7.7.2 Biotest Business Overview
7.7.3 Biotest Human Plasma Protein Products Major Product Offerings
7.7.4 Biotest Human Plasma Protein Products Revenue in Global Market (2018-2023)
7.7.5 Biotest Key News & Latest Developments
7.8 BPL
7.8.1 BPL Company Summary
7.8.2 BPL Business Overview
7.8.3 BPL Human Plasma Protein Products Major Product Offerings
7.8.4 BPL Human Plasma Protein Products Revenue in Global Market (2018-2023)
7.8.5 BPL Key News & Latest Developments
7.9 RAAS
7.9.1 RAAS Company Summary
7.9.2 RAAS Business Overview
7.9.3 RAAS Human Plasma Protein Products Major Product Offerings
7.9.4 RAAS Human Plasma Protein Products Revenue in Global Market (2018-2023)
7.9.5 RAAS Key News & Latest Developments
7.10 CBPO
7.10.1 CBPO Company Summary
7.10.2 CBPO Business Overview
7.10.3 CBPO Human Plasma Protein Products Major Product Offerings
7.10.4 CBPO Human Plasma Protein Products Revenue in Global Market (2018-2023)
7.10.5 CBPO Key News & Latest Developments
7.11 Hualan Bio
7.11.1 Hualan Bio Company Summary
7.11.2 Hualan Bio Business Overview
7.11.3 Hualan Bio Human Plasma Protein Products Major Product Offerings
7.11.4 Hualan Bio Human Plasma Protein Products Revenue in Global Market (2018-2023)
7.11.5 Hualan Bio Key News & Latest Developments
7.12 Tiantan Bio
7.12.1 Tiantan Bio Company Summary
7.12.2 Tiantan Bio Business Overview
7.12.3 Tiantan Bio Human Plasma Protein Products Major Product Offerings
7.12.4 Tiantan Bio Human Plasma Protein Products Revenue in Global Market (2018-2023)
7.12.5 Tiantan Bio Key News & Latest Developments
7.13 Shuanglin Bio
7.13.1 Shuanglin Bio Company Summary
7.13.2 Shuanglin Bio Business Overview
7.13.3 Shuanglin Bio Human Plasma Protein Products Major Product Offerings
7.13.4 Shuanglin Bio Human Plasma Protein Products Revenue in Global Market (2018-2023)
7.13.5 Shuanglin Bio Key News & Latest Developments
7.14 Boya Bio
7.14.1 Boya Bio Company Summary
7.14.2 Boya Bio Business Overview
7.14.3 Boya Bio Human Plasma Protein Products Major Product Offerings
7.14.4 Boya Bio Human Plasma Protein Products Revenue in Global Market (2018-2023)
7.14.5 Boya Bio Key News & Latest Developments
7.15 Yuanda Shuyang
7.15.1 Yuanda Shuyang Company Summary
7.15.2 Yuanda Shuyang Business Overview
7.15.3 Yuanda Shuyang Human Plasma Protein Products Major Product Offerings
7.15.4 Yuanda Shuyang Human Plasma Protein Products Revenue in Global Market (2018-2023)
7.15.5 Yuanda Shuyang Key News & Latest Developments
7.16 Weiguang Bio
7.16.1 Weiguang Bio Company Summary
7.16.2 Weiguang Bio Business Overview
7.16.3 Weiguang Bio Human Plasma Protein Products Major Product Offerings
7.16.4 Weiguang Bio Human Plasma Protein Products Revenue in Global Market (2018-2023)
7.16.5 Weiguang Bio Key News & Latest Developments
7.17 Nanyue Bio
7.17.1 Nanyue Bio Company Summary
7.17.2 Nanyue Bio Business Overview
7.17.3 Nanyue Bio Human Plasma Protein Products Major Product Offerings
7.17.4 Nanyue Bio Human Plasma Protein Products Revenue in Global Market (2018-2023)
7.17.5 Nanyue Bio Key News & Latest Developments
7.18 KM Biologics
7.18.1 KM Biologics Company Summary
7.18.2 KM Biologics Business Overview
7.18.3 KM Biologics Human Plasma Protein Products Major Product Offerings
7.18.4 KM Biologics Human Plasma Protein Products Revenue in Global Market (2018-2023)
7.18.5 KM Biologics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Human Plasma Protein Products Market Opportunities & Trends in Global Market
Table 2. Human Plasma Protein Products Market Drivers in Global Market
Table 3. Human Plasma Protein Products Market Restraints in Global Market
Table 4. Key Players of Human Plasma Protein Products in Global Market
Table 5. Top Human Plasma Protein Products Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Human Plasma Protein Products Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Human Plasma Protein Products Revenue Share by Companies, 2018-2023
Table 8. Global Companies Human Plasma Protein Products Product Type
Table 9. List of Global Tier 1 Human Plasma Protein Products Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Human Plasma Protein Products Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Human Plasma Protein Products Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Human Plasma Protein Products Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Human Plasma Protein Products Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Human Plasma Protein Products Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Human Plasma Protein Products Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Human Plasma Protein Products Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Human Plasma Protein Products Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Human Plasma Protein Products Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Human Plasma Protein Products Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Human Plasma Protein Products Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Human Plasma Protein Products Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Human Plasma Protein Products Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Human Plasma Protein Products Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Human Plasma Protein Products Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Human Plasma Protein Products Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Human Plasma Protein Products Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Human Plasma Protein Products Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Human Plasma Protein Products Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Human Plasma Protein Products Revenue, (US$, Mn), 2024-2029
Table 30. Takeda Company Summary
Table 31. Takeda Human Plasma Protein Products Product Offerings
Table 32. Takeda Human Plasma Protein Products Revenue (US$, Mn) & (2018-2023)
Table 33. Takeda Key News & Latest Developments
Table 34. CSL Company Summary
Table 35. CSL Human Plasma Protein Products Product Offerings
Table 36. CSL Human Plasma Protein Products Revenue (US$, Mn) & (2018-2023)
Table 37. CSL Key News & Latest Developments
Table 38. Grifols Company Summary
Table 39. Grifols Human Plasma Protein Products Product Offerings
Table 40. Grifols Human Plasma Protein Products Revenue (US$, Mn) & (2018-2023)
Table 41. Grifols Key News & Latest Developments
Table 42. Octapharma Company Summary
Table 43. Octapharma Human Plasma Protein Products Product Offerings
Table 44. Octapharma Human Plasma Protein Products Revenue (US$, Mn) & (2018-2023)
Table 45. Octapharma Key News & Latest Developments
Table 46. Kedrion Company Summary
Table 47. Kedrion Human Plasma Protein Products Product Offerings
Table 48. Kedrion Human Plasma Protein Products Revenue (US$, Mn) & (2018-2023)
Table 49. Kedrion Key News & Latest Developments
Table 50. LFB Group Company Summary
Table 51. LFB Group Human Plasma Protein Products Product Offerings
Table 52. LFB Group Human Plasma Protein Products Revenue (US$, Mn) & (2018-2023)
Table 53. LFB Group Key News & Latest Developments
Table 54. Biotest Company Summary
Table 55. Biotest Human Plasma Protein Products Product Offerings
Table 56. Biotest Human Plasma Protein Products Revenue (US$, Mn) & (2018-2023)
Table 57. Biotest Key News & Latest Developments
Table 58. BPL Company Summary
Table 59. BPL Human Plasma Protein Products Product Offerings
Table 60. BPL Human Plasma Protein Products Revenue (US$, Mn) & (2018-2023)
Table 61. BPL Key News & Latest Developments
Table 62. RAAS Company Summary
Table 63. RAAS Human Plasma Protein Products Product Offerings
Table 64. RAAS Human Plasma Protein Products Revenue (US$, Mn) & (2018-2023)
Table 65. RAAS Key News & Latest Developments
Table 66. CBPO Company Summary
Table 67. CBPO Human Plasma Protein Products Product Offerings
Table 68. CBPO Human Plasma Protein Products Revenue (US$, Mn) & (2018-2023)
Table 69. CBPO Key News & Latest Developments
Table 70. Hualan Bio Company Summary
Table 71. Hualan Bio Human Plasma Protein Products Product Offerings
Table 72. Hualan Bio Human Plasma Protein Products Revenue (US$, Mn) & (2018-2023)
Table 73. Hualan Bio Key News & Latest Developments
Table 74. Tiantan Bio Company Summary
Table 75. Tiantan Bio Human Plasma Protein Products Product Offerings
Table 76. Tiantan Bio Human Plasma Protein Products Revenue (US$, Mn) & (2018-2023)
Table 77. Tiantan Bio Key News & Latest Developments
Table 78. Shuanglin Bio Company Summary
Table 79. Shuanglin Bio Human Plasma Protein Products Product Offerings
Table 80. Shuanglin Bio Human Plasma Protein Products Revenue (US$, Mn) & (2018-2023)
Table 81. Shuanglin Bio Key News & Latest Developments
Table 82. Boya Bio Company Summary
Table 83. Boya Bio Human Plasma Protein Products Product Offerings
Table 84. Boya Bio Human Plasma Protein Products Revenue (US$, Mn) & (2018-2023)
Table 85. Boya Bio Key News & Latest Developments
Table 86. Yuanda Shuyang Company Summary
Table 87. Yuanda Shuyang Human Plasma Protein Products Product Offerings
Table 88. Yuanda Shuyang Human Plasma Protein Products Revenue (US$, Mn) & (2018-2023)
Table 89. Yuanda Shuyang Key News & Latest Developments
Table 90. Weiguang Bio Company Summary
Table 91. Weiguang Bio Human Plasma Protein Products Product Offerings
Table 92. Weiguang Bio Human Plasma Protein Products Revenue (US$, Mn) & (2018-2023)
Table 93. Weiguang Bio Key News & Latest Developments
Table 94. Nanyue Bio Company Summary
Table 95. Nanyue Bio Human Plasma Protein Products Product Offerings
Table 96. Nanyue Bio Human Plasma Protein Products Revenue (US$, Mn) & (2018-2023)
Table 97. Nanyue Bio Key News & Latest Developments
Table 98. KM Biologics Company Summary
Table 99. KM Biologics Human Plasma Protein Products Product Offerings
Table 100. KM Biologics Human Plasma Protein Products Revenue (US$, Mn) & (2018-2023)
Table 101. KM Biologics Key News & Latest Developments
List of Figures
Figure 1. Human Plasma Protein Products Segment by Type in 2022
Figure 2. Human Plasma Protein Products Segment by Application in 2022
Figure 3. Global Human Plasma Protein Products Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Human Plasma Protein Products Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Human Plasma Protein Products Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Human Plasma Protein Products Revenue in 2022
Figure 8. By Type - Global Human Plasma Protein Products Revenue Market Share, 2018-2029
Figure 9. By Application - Global Human Plasma Protein Products Revenue Market Share, 2018-2029
Figure 10. By Type - Global Human Plasma Protein Products Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Human Plasma Protein Products Revenue Market Share, 2018-2029
Figure 12. By Application - Global Human Plasma Protein Products Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Human Plasma Protein Products Revenue Market Share, 2018-2029
Figure 14. By Region - Global Human Plasma Protein Products Revenue Market Share, 2018-2029
Figure 15. By Country - North America Human Plasma Protein Products Revenue Market Share, 2018-2029
Figure 16. US Human Plasma Protein Products Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Human Plasma Protein Products Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Human Plasma Protein Products Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Human Plasma Protein Products Revenue Market Share, 2018-2029
Figure 20. Germany Human Plasma Protein Products Revenue, (US$, Mn), 2018-2029
Figure 21. France Human Plasma Protein Products Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Human Plasma Protein Products Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Human Plasma Protein Products Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Human Plasma Protein Products Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Human Plasma Protein Products Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Human Plasma Protein Products Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Human Plasma Protein Products Revenue Market Share, 2018-2029
Figure 28. China Human Plasma Protein Products Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Human Plasma Protein Products Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Human Plasma Protein Products Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Human Plasma Protein Products Revenue, (US$, Mn), 2018-2029
Figure 32. India Human Plasma Protein Products Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Human Plasma Protein Products Revenue Market Share, 2018-2029
Figure 34. Brazil Human Plasma Protein Products Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Human Plasma Protein Products Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Human Plasma Protein Products Revenue Market Share, 2018-2029
Figure 37. Turkey Human Plasma Protein Products Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Human Plasma Protein Products Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Human Plasma Protein Products Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Human Plasma Protein Products Revenue, (US$, Mn), 2018-2029
Figure 41. Takeda Human Plasma Protein Products Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. CSL Human Plasma Protein Products Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Grifols Human Plasma Protein Products Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Octapharma Human Plasma Protein Products Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Kedrion Human Plasma Protein Products Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. LFB Group Human Plasma Protein Products Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Biotest Human Plasma Protein Products Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. BPL Human Plasma Protein Products Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. RAAS Human Plasma Protein Products Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. CBPO Human Plasma Protein Products Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Hualan Bio Human Plasma Protein Products Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Tiantan Bio Human Plasma Protein Products Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Shuanglin Bio Human Plasma Protein Products Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Boya Bio Human Plasma Protein Products Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Yuanda Shuyang Human Plasma Protein Products Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Weiguang Bio Human Plasma Protein Products Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Nanyue Bio Human Plasma Protein Products Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. KM Biologics Human Plasma Protein Products Revenue Year Over Year Growth (US$, Mn) & (2018-2023)



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • ヒト血漿分画製品のグローバル市場展望 2023年-2029年：免疫グロブリン、凝固因子、アルブミン、その他
  • ヒトGFAPキットのグローバル市場展望 2023年-2029年：ヒトGFAP CLIAキット、ヒトGFAP ELISAキット、その他
  • 低温過酸化水素プラズマ滅菌装置のグローバル市場展望 2023年-2029年：100L以下、100～200L、200L以上
  • ヒト破傷風用免疫グロブリンのグローバル市場展望 2023年-2029年：注射剤、フリーズドライ注射剤
  • ヒトHCVIgMELISA検査キットのグローバル市場展望 2023年-2029年：300テストストリップ、600テストストリップ
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14366 )"ヒト血漿タンパク質製品のグローバル市場展望 2023年-2029年：免疫グロブリン、凝固因子、アルブミン、その他" (英文：Human Plasma Protein Products Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。